Author:
Alelyani Rakan H,Alghamdi Ali H,Almughamisi Thamer A,Alshareef Abdulrahman M,Kadasa Abdulaziz N,Alrajhi Amir M,Alburayk Abdullah K,Barefah Ahmed S,Radhwi Osman O,Almohammadi Abdullah T,Bahashawan Salem M,AlAhwal Hatem M
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Cancer incidence report. Saudi Arabia 2015. (2015). Accessed. January 8, 2023: https://nhic.gov.sa/eServices/Documents/E%20SCR%20final%206%20NOV.pdf.
2. Rituximab as first-line and maintenance therapy for patients with indolent non-Hodgkin's lymphoma;Hainsworth JD;J Clin Oncol,2002
3. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead;Minard-Colin V;J Clin Oncol,2015
4. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann W;Blood,2005
5. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response;Rehermann B;Nat Med,1996
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献